L. Galluzzi, I. Vitale, and S. A. Aaronson, Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018, Cell Death and Differentiation, vol.25, issue.3, pp.486-541, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01727577

G. Kroemer, L. Galluzzi, and P. Vandenabeele, Classification of cell death: recommendations of the nomenclature committee on cell death, Cell Death & Differentiation, vol.16, issue.1, pp.3-11, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00407686

D. Tang, R. Kang, T. V. Berghe, P. Vandenabeele, and G. Kroemer, e molecular machinery of regulated cell death, Cell Research, vol.29, issue.5, pp.347-364, 2019.

A. Ashkenazi and G. Salvesen, Regulated cell death: signaling and mechanisms, Annual Review of Cell and Developmental Biology, vol.30, issue.1, pp.337-356, 2014.

S. Nagata, Apoptosis and clearance of apoptotic cells, Annual Review of Immunology, vol.36, issue.1, 2018.

S. Elmore, Apoptosis: a review of programmed cell death, Toxicologic Pathology, vol.35, issue.4, pp.495-516, 2007.

R. Singh, A. Letai, and K. Sarosiek, Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins, Nature Reviews Molecular Cell Biology, vol.20, issue.3, pp.175-193, 2019.

K. Karrm and B. Johansson, Pediatric T-cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, vol.56, issue.2, pp.549-550, 2017.

T. Terwilliger and M. Abdul-hay, Acute lymphoblastic leukemia: a comprehensive review and 2017 update, Blood Cancer Journal, vol.7, issue.6, p.577, 2017.

J. Rutering, M. Ilmer, and A. Recio, Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia, Nature Reviews Drug Discovery, vol.5, issue.6, pp.1-8, 2016.

A. D. Jacobs and R. P. Gale, Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults, New England Journal of Medicine, vol.311, issue.19, pp.1219-1231, 1984.

S. J. Oiseth and M. S. Aziz, Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead, Journal of Cancer Metastasis and Treatment, vol.3, issue.10, p.250, 2017.

A. Anusha, S. Kumar, S. Kaushik, and A. Jyoti, Cancer immunotherapy, Journal of Pharmaceutical Sciences and Research, vol.9, issue.5, pp.662-666, 2017.

H. H. Lara, L. I. Turrent, E. N. Garza-treviño, R. Tamez-guerra, and C. Rodríguez-padilla, Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant, Experimental and erapeutic Medicine, vol.1, issue.4, pp.603-610, 2010.

M. A. Franco-molina, E. Mendoza-gamboa, and P. Zapata-benavides, IMMUNEPOTENT CRP (bovine dialyzable leukocyte extract) adjuvant immunotherapy: a phase I study in non-small cell lung cancer patients, Cytotherapy, vol.10, issue.5, pp.490-496, 2008.

M. A. Franco-molina, S. E. Santana-krímskaya, and E. E. Coronado-cerda, Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment, Biotechnology & Biotechnological Equipment, vol.32, issue.4, pp.1028-1035, 2018.

E. E. Coronado-cerda, M. A. Franco-molina, and E. Mendoza-gamboa, In vivo chemoprotective activity of bovine dialyzable leukocyte extract in mouse bone marrow cells against damage induced by 5-fluorouracil, Journal of Immunology Research, vol.2016, 2016.

M. A. Franco-molina, E. Mendoza-gamboa, and P. Castillo-tello, Bovine dialyzable leukocyte extract modulates cytokines and nitric oxide production in lipopolysaccharidestimulated human blood cells, Cytotherapy, vol.9, issue.4, pp.379-385, 2007.

M. A. Franco-molina, E. Mendoza-gamboa, L. Castillo-león, R. S. Tamez-guerra, C. Rodríguez-padilla et al., Bovine dialyzable leukocyte extract modulates the nitric oxide and pro-inflammatory cytokine production in lipopolysaccharide-stimulated murine peritoneal Macro-phagesIn vitro, Journal of Medicinal Food, vol.8, issue.1, pp.20-26, 2005.

M. A. Franco-molina, E. Mendoza-gamboa, and D. Miranda-hernández, In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells, Cytotherapy, vol.8, issue.4, pp.408-414, 2006.

A. C. Martínez-torres, A. Reyes-ruiz, M. Benítez-londoño, M. A. Franco-molina, and C. Rodríguez-padilla, IMMU-NEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production, BMC Cancer, vol.18, issue.1, p.13, 2018.

E. Mendoza-gamboa, M. A. Franco-molina, and P. Zapata-benavides, Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells, Cytotherapy, vol.10, issue.2, pp.212-219, 2008.

A. C. Martinez-torres, L. Gomez-morales, A. B. Martinez-loria, A. C. Uscanga-palomeque, J. M. Vazquez-guillen et al., Cytotoxic activity of IMMUNEPO-TENT CRP against non-small cell lung cancer cell lines, PeerJ, vol.7, 2019.

A. Kinner, W. Wu, C. Staudt, and G. Iliakis, Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin, Nucleic Acids Research, vol.36, issue.17, pp.5678-5694, 2008.

A. C. Martínez-torres, D. Zarate-triviño, and H. Y. Lorenzo-anota, Chitosan gold nanoparticles induce cell death in hela and MCF-7 cells through reactive oxygen species production, International Journal of Nanomedicine, vol.13, pp.3235-3250, 2018.

S. W. Tait and D. R. Green, Mitochondrial regulation of cell death, Cold Spring Harbor Perspectives in Biology, vol.5, issue.9, 2013.

G. Xu and Y. Shi, Apoptosis signaling pathways and lymphocyte homeostasis, Cell Research, vol.17, issue.9, pp.759-771, 2007.

M. Redza-dutordoir and D. A. Averill-bates, Activation of apoptosis signalling pathways by reactive oxygen species, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol.1863, issue.12, pp.2977-2992, 2016.

M. A. Hernández-esquivel, A. Pérez-torres, and L. Romero-romero, e dialyzable leukocyte extract Trans-feronTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer, Biomedicine & Pharmacotherapy, vol.101, pp.938-944, 2018.

V. Pestell, S. Peter, and G. Hr?ková, Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer, Biomedicine and Pharmacotherapy, vol.89, pp.245-256, 2017.

P. Solár, V. Sa?ková, and G. Hr?ková, Antitumor effect of the combination of manumycin A and immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model, Oncology Reports, vol.37, issue.1, pp.368-378, 2017.

C. A. Sierra-rivera, M. A. Franco-molina, and E. Mendoza-gamboa, Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells, Oncology Letters, vol.12, issue.6, pp.4449-4460, 2016.

D. R. Green, N. Droin, and M. Pinkoski, Activation-induced cell death in T cells, Immunological Reviews, vol.193, issue.1, pp.70-81, 2003.

K. Yao, H. C. Xing, and B. Wu, Effect of TIEG1 on apoptosis and expression of Bcl-2/Bax and Pten in leukemic cell lines, Genetics and Molecular Research, vol.14, issue.1, pp.1968-1974, 2015.

R. M. Mohammad, I. Muqbil, and L. Lowe, Broad targeting of resistance to apoptosis in cancer, Seminars in Cancer Biology, vol.35, pp.78-103, 2015.

K. J. Campbell and S. W. Tait, Targeting BCL-2 regulated apoptosis in cancer, Open Biology, vol.8, issue.5, 2018.

A. Ghasemi, T. Khanzadeh, and M. Z. Heydarabad, Evaluation of BAX and BCL-2 gene expression and apoptosis induction in acute lymphoblastic leukemia cell line CCRFCEM after high-dose prednisolone treatment, Asian Pacific Journal of Cancer Prevention, vol.19, issue.8, pp.2319-2323, 2018.

H. M. Al-aamri, H. Ku, and H. R. Irving, Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia, BMC Cancer, vol.19, issue.1, pp.1-12, 2019.

S. Soubeyrand, L. Pope, and R. J. Haché, Topoisomerase II?-dependent induction of a persistent DNA damage response in response to transient etoposide exposure, Molecular Oncology, vol.4, issue.1, pp.38-51, 2010.

E. Winter, L. D. Chiaradia, A. H. Silva, R. J. Nunes, R. A. Yunes et al., Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action, Toxicology in Vitro, vol.28, issue.5, pp.769-777, 2014.

S. Galadari, A. Rahman, S. Pallichankandy, and F. , Reactive oxygen species and cancer paradox: to promote or to suppress, Free Radical Biology and Medicine, vol.104, pp.144-164, 2017.

E. L. Walton, e dual role of ROS, antioxidants and autophagy in cancer, Biomedical Journal, vol.39, issue.2, pp.89-92, 2016.

P. S. Hole, R. L. Darley, and A. Tonks, Do reactive oxygen species play a role in myeloid leukemias, Blood, vol.117, issue.22, pp.5816-5826, 2011.

A. Apraiz, J. Idkowiak-baldys, N. Nieto-rementería, M. D. Boyano, Y. A. Hannun et al., Dihydroceramide accumulation and reactive oxygen species are distinct and non essential events in 4-HPR mediated leukemia cell death aintzane, Biochemistry and Cell Biology, vol.90, issue.2, pp.233-236, 2012.

Y. Jiao, S. Ma, and Y. Wang, N-acetyl cysteine depletes reactive oxygen species and prevents dental monomer-induced intrinsic mitochondrial apoptosis in vitro in human dental pulp cells, PLoS One, vol.11, issue.1, 2016.

T. Sato, T. Machida, and Y. Sato, Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in jurkat cells, Journal of Immunology, vol.173, issue.1, pp.285-296, 2004.

A. C. Martinez-torres, H. Y. Lorenzo-anota, M. G. García-juárez, D. G. Zárate-triviño, and C. Rodriguez-padilla, Chitosan gold nanoparticles induce different ROS-dependent cell death modalities in leukemic cells, International Journal of Nanomedicine, vol.14, pp.7173-7190, 2019.

N. Zhang, H. Hartig, I. Dzhagalov, D. Draper, and Y. W. He, e role of apoptosis in the development and function of T lymphocytes, Cell Research, vol.15, issue.10, pp.749-769, 2005.